Results 1 to 10 of about 1,541,059 (150)

Clinical Utility of the aMAP Score for Predicting Hepatocellular Carcinoma Development in Patients with Chronic Hepatitis B [PDF]

Diagnostics
This study aimed to evaluate the efficacy of the aMAP score and compare it with other risk scores for predicting hepatocellular carcinoma (HCC) development in Thai patients with chronic hepatitis B (CHB).
Supakorn Chaiwiriyawong, Suraphon Assawasuwannakit, Poorikorn Feuangwattana, Pimsiri Sripongpun, Naichaya Chamroonkul, Teerha Piratvisuth, Apichat Kaewdech   +6 more
doaj   +7 more sources

aMAP Score as a Predictor for Long-Term Outcomes in Patients with HBV-Related Acute-on-Chronic Liver Failure [PDF]

International Journal of General Medicine, 2022
Yunqing Sun,* Zhuohong Li,* Guichan Liao, Muye Xia, Xuwen Xu, Shaohang Cai, Jie Peng Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong Province, People’s Republic of China*These authors ...
Sun Y, Li Z, Liao G, Xia M, Xu X, Cai S, Peng J   +6 more
doaj   +5 more sources

The aMAP score improves discrimination of prognostic models in hepatocellular carcinoma after radiofrequency ablation [PDF]

Frontiers in Oncology
PurposeThe aMAP score has proven a reliable model for predicting the risk of hepatocellular carcinoma (HCC) development in patients with various types of hepatitis, but its value in predicting recurrence in HCC patients after radiofrequency ablation (RFA)
Luchang Fan, Yiyan Zhang, Jianmin Ding, Yan Zhou, Jun Li, Qiong Wu, Shuqin Cheng, Fengmei Wang, Fengmei Wang, Xiang Jing   +9 more
doaj   +3 more sources

Association between the aMAP risk score and mortality in the MASLD/MetALD/ALD patient population: a cohort study [PDF]

Frontiers in Medicine
BackgroundThe age–male–ALBI–platelets (aMAP) risk score, an emerging non-invasive marker for liver fibrosis and hepatocellular carcinoma, has shown potential in risk stratification.
Peng-yang Li, Yuan-xin Mo, Rui-biao Fu, Jian Song, Shao-lei Kuang, Yuan-quan Zhao, Wei Jiang, Xiao-feng Dong   +7 more
doaj   +3 more sources

The aMAP score combined with plasma cfDNA methylation testing for risk stratification in hepatitis population: a case-control study [PDF]

Scientific Reports
Effective surveillance of the hepatitis populations reduces liver cancer incidence and improves prognosis. This study aimed to develop an easy and non-invasive risk assessment model for this population.
Dianyan Chen, Ka Zhang, Tingyong Lv, Xuezhong Jian, Jin Zhang, Yinghong An, Dingyao Ren, Fei Long, Sandu Liu   +8 more
doaj   +3 more sources

External Validation of aMAP Hepatocellular Carcinoma Risk Score in Patients With Chronic Hepatitis B-Related Cirrhosis Receiving ETV or TDF Therapy [PDF]

Frontiers in Medicine, 2021
Background and Aim: A prediction model of hepatocellular carcinoma (HCC) risk in patients with chronic liver diseases, based on age, male sex, albumin-bilirubin, and platelets (aMAP), has been previously reported. We validated the aMAP score and compared
Honglian Gui, Yan Huang, Gangde Zhao, Lichang Chen, Wei Cai, Hui Wang, Qing Guo, Qing Xie   +7 more
doaj   +5 more sources

HCC risk stratification scores: insights from large multi-center national cohort study [PDF]

Scientific Reports
Current guidelines advocate biannual HCC surveillance for chronic hepatitis C patients who achieved sustained virological response (SVR) following direct acting antivirals (DAAs), posing a heavy burden on healthcare systems.
Imam Waked, Gamal Esmat, Mohamed Abdallah, Aisha Elsharkawy, Wafaa Elakel, Islam Ammar, Ehab Kamal, Mohamed Hassany, Nabiel Mikhail, Riham Soliman, Wahid Doss, Gamal Shiha   +11 more
doaj   +2 more sources

Impact of cardiometabolic risk factors on hepatocellular carcinoma incidence in patients with chronic hepatitis B: A retrospective cohort study. [PDF]

PLoS ONE
Background and aimsChronic hepatitis B virus (HBV) infection remains a major global health burden and a leading cause of hepatocellular carcinoma (HCC).
Chanavee Toh, Kedsiree Sanit, Pimsiri Sripongpun, Naichaya Chamroonkul, Suthat Liangpunsakul, Teerha Piratvisuth, Apichat Kaewdech   +6 more
doaj   +2 more sources

Comparative evaluation of regression and machine-learning models for hepatocellular carcinoma risk stratification across diverse aetiologies [PDF]

JHEP Reports
Background & Aims: We aimed to develop machine learning (ML) models for hepatocellular carcinoma (HCC) risk stratification in patients with cirrhosis and to test their ability to identify those with an annual HCC incidence >3%, for whom more ...
Pierre Nahon, Richard Layese, Pierre-André Natella, Lucia Parlati, Tounes Saidi, Nathalie Ganne-Carrié, Gisèle N’Kontchou, Cendrine Chaffaut, Jean-Charles Nault, Jessica Bamba-Funck, Angela Sutton, Clovis Lusivika Nzinga, Fabrice Carrat, Etienne Audureau   +13 more
doaj   +2 more sources

A stratified precision screening strategy for enhancing hepatitis B- and C-associated liver cancer detection: a prospective study [PDF]

Scientific Reports
This study explores new screening strategies to enhance liver cancer screening effectiveness. In a prospective study, 2605 participants underwent baseline, 6-months self-reported, and 1-year follow-up screenings using abdominal ultrasonography, AFP, AFP ...
Hua He, Yanhua Wu, Zhifang Jia, Yangyu Zhang, Yuchen Pan, Yuzheng Zhang, Kaisheng Su, Yingnan Cui, Yuanlin Sun, Dongming Li, Haiyong Lv, Jiaxin Yi, Yuehui Wang, Changgui Kou, Xiaofeng Sun, Jing Jiang   +15 more
doaj   +2 more sources